💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Jazz Pharmaceuticals plc (JAZZ)
« Back to company indexJAZZ Chatter Timeline
Stock Ticker for JAZZ
Most Active Tweeters for JAZZ
| User | Tweets |
|---|---|
| @MarcJacksonLA | 4 |
| @quantisnow | 3 |
| @Tickeron | 3 |
| @Ba4Saso | 3 |
| @bthefirsttoknow | 2 |
Recent Tweets for JAZZ
 |
@newsfilterio $373,444.68 of shares sold by Cozadd Bruce C (Chairman & CEO), reported in a new form 4 filed with the SEC $JAZZ https://t.co/BbESdcwcnJ 2:12am |
 |
@day_trading_de JAZZ (Jazz Pharmaceuticals plc) ? #Insider #stock alert! ? #Sale on 2021-12-01 - $JAZZ ??: COZADD BRUCE C (Chairman… https://t.co/HwJPPhLEgg December 3rd 2021, 9:12pm |
 |
@fintel_io Insider Bruce C Cozadd reports selling 6,748 shares of $JAZZ for a total cost of $827,725.68 https://t.co/A6KEOTAUFM #FNTL December 3rd 2021, 9:12pm |
 |
@PetterTrade $JAZZ Awaiting Short Signal. Stock Trading Ideas by https://t.co/jZvLPc7Llw https://t.co/EBfdyIIk4B December 2nd 2021, 2:12pm |
 |
@ElsayadAbdallah $JAZZ Awaiting Buy Signal. Stock Trading Ideas by https://t.co/WBzNMhZu5y https://t.co/7jcH1HuGhV December 2nd 2021, 2:12pm |
 |
@popularinvestor High time to start breaking down $JAZZ during this rout. GW had incredible potential. December 2nd 2021, 8:12am |
 |
@TradingChromat1 Awaiting Short signal on $JAZZ https://t.co/s1afeKOV5Q December 1st 2021, 8:12pm |
 |
@MarcJacksonLA $JAZZ Jazz Pharmaceuticals to Present from Expanding Neuroscience Portfolio Epidiolex® (cannabidiol) Oral Solution… https://t.co/fUd5WOmfS6 December 1st 2021, 2:12pm |
 |
@Ba4Saso $JAZZ Waiting for Buy signal on JAZZ with https://t.co/DFtBhic4Wk https://t.co/tz9GuSVPrb December 1st 2021, 1:12pm |
 |
@FlashAlert_me $JAZZ [15s. delayed]: Issued Press Release on December 01, 07:45:00: Jazz Pharmaceuticals to Present from Expanding… https://t.co/PtxYkLttoG December 1st 2021, 12:12pm |
 |
@OryoJohn $JAZZ - to Present from Expanding Neuroscience Portfolio Epidiolex® (cannabidiol) Oral Solution Data at the 2021 A… https://t.co/9u1flB64Qo December 1st 2021, 12:12pm |
 |
@StockNewsBot2 $JAZZ Jazz Pharmaceuticals to Present from Expanding Neuroscience Portfolio Epidiolex® (cannabidiol) Oral Solution… https://t.co/10ez8Dgu9n December 1st 2021, 12:12pm |
 |
@quantisnow $JAZZ ? Jazz Pharmaceuticals to Present from Expanding Neuroscience Portfolio Epidiolex® (cannabidiol) Oral Solutio… https://t.co/UsKojDxTYp December 1st 2021, 12:12pm |
 |
@stock_titan $JAZZ Jazz Pharmaceuticals to Present from Expanding Neuroscience Portfolio Epidiolex® (cannabidiol) Oral Solution… https://t.co/wMmvvlQd34 December 1st 2021, 12:12pm |
 |
@Tickeron A.I.dvisor made a bearish call on $JAZZ, netting in a 8.33% gain over 3 weeks #JazzPharmaceuticals #stockmarket… https://t.co/QF7KNsGrwA December 1st 2021, 1:12am |
|
@Tickeron A.I.dvisor made a bearish call on $JAZZ, netting in a 11.59% gain over 1 month #JazzPharmaceuticals #stockmarket… https://t.co/7p6rcwro3L November 30th 2021, 10:11pm |
 |
@Kostarof RT @BertrandBio: $Jazz Announces 1st Patient Enrolled in IMforte Phase 3 Trial Evaluating $PHM Zepzelca (lurbinectedin) in Combination with… November 30th 2021, 9:11pm |
 |
@CostaTejedor RT @GeorgeB14941177: $JAZZ Jazz Pharmaceuticals Announces First Patient Enrolled in IMforte Phase 3 Trial Evaluating Zepzelca® (lurbinected… November 30th 2021, 9:11pm |
|
@Tickeron A.I.dvisor made a bearish call on $JAZZ, netting in a 9.37% gain over 3 weeks #JazzPharmaceuticals #stockmarket… https://t.co/qb354jPCsz November 30th 2021, 8:11pm |
 |
@BertrandBio $Jazz Announces 1st Patient Enrolled in IMforte Phase 3 Trial Evaluating $PHM Zepzelca (lurbinectedin) in Combinati… https://t.co/vjGfQdEbCG November 30th 2021, 3:11pm |
 |
@pistoto2017 RT @MarcJacksonLA: $JAZZ Jazz Pharmaceuticals Announces First Patient Enrolled in IMforte Phase 3 Trial Evaluating Zepzelca® (lurbinectedin… November 30th 2021, 3:11pm |
 |
@GeorgeB14941177 $JAZZ Jazz Pharmaceuticals Announces First Patient Enrolled in IMforte Phase 3 Trial Evaluating Zepzelca® (lurbinec… https://t.co/8K5WsIg1ej November 30th 2021, 2:11pm |
|
@MarcJacksonLA $JAZZ Jazz Pharmaceuticals Announces First Patient Enrolled in IMforte Phase 3 Trial Evaluating Zepzelca® (lurbinec… https://t.co/tljGNbmhrO November 30th 2021, 1:11pm |
 |
@vtmtrading Jazz enrolls first patient in Phase 3 clinical trial evaluating Zepzelca $JAZZ November 30th 2021, 1:11pm |
 |
@bthefirsttoknow First out// $JAZZ: Jazz Pharmaceuticals Announces First Patient Enrolled In IMforte Phase 3 Trial Evaluating Zepzel… https://t.co/NyEdJ6L8ek November 30th 2021, 1:11pm |
 |
@QuantchaIdeas StockTwits Trending Alert: Trading recent interest in JAZZ PHARMACEUTICALS $JAZZ https://t.co/E772CJUb81 November 30th 2021, 1:11pm |
|
@StockNewsBot2 $JAZZ Jazz Pharmaceuticals Announces First Patient Enrolled in IMforte Phase 3 Trial Evaluating Zepzelca® (lurbinec… https://t.co/kAGA0stk10 November 30th 2021, 1:11pm |
|
@quantisnow $JAZZ ? Jazz Pharmaceuticals Announces First Patient Enrolled in IMforte Phase 3 Trial Evaluating Zepzelca® (lurbin… https://t.co/k7s4cDv0Gb November 30th 2021, 1:11pm |
|
@stock_titan $JAZZ Jazz Pharmaceuticals Announces First Patient Enrolled in IMforte Phase 3 Trial Evaluating Zepzelca® (lurbinec… https://t.co/SYuHMc0Utf November 30th 2021, 1:11pm |
|
@OryoJohn $JAZZ: Jazz Pharmaceuticals Announces Commercial Availability in Canada of Zepzelca (lurbinectedin), the First New… https://t.co/aJB3Eye8ps November 30th 2021, 12:11pm |
|
@quantisnow $JAZZ ? Jazz Pharmaceuticals Announces Commercial Availability in Canada of Zepzelca™ (lurbinectedin), the First Ne… https://t.co/qumctnNS4I November 30th 2021, 12:11pm |
|
@bthefirsttoknow First out// $JAZZ: Jazz Pharmaceuticals Announces Commercial Availability in Canada of Zepzelca (lurbinectedin), th… https://t.co/iniY48HBxI November 30th 2021, 12:11pm |
 |
@ElectronIII $JAZZ - Largest trade since 6/18/21. https://t.co/EOwKk6bRuA November 30th 2021, 3:11am |
 |
@SwingTradeBot New 52 Week Low today: $JAZZ ... https://t.co/0EM4q8YtyQ November 29th 2021, 7:11pm |
|
@ElsayadAbdallah $JAZZ Awaiting buy signal. Algo Trading Ideas by https://t.co/WBzNMhZu5y https://t.co/jCmns0o6oX November 29th 2021, 11:11am |
 |
@worldcannanews1 RT @MarcJacksonLA: $JAZZ Trial of Jazz’ cannabis drug in glioblastoma will start next year https://t.co/5BYDM2ZnHR via @pharmaphorum November 28th 2021, 3:11pm |
|
@MarcJacksonLA $JAZZ Trial of Jazz’ cannabis drug in glioblastoma will start next year https://t.co/5BYDM2ZnHR via @pharmaphorum November 28th 2021, 3:11pm |
|
@TradingChromat1 Awaiting Buy signal on $JAZZ https://t.co/xCdkqPajZ1 November 26th 2021, 5:11pm |
|
@Ba4Saso $JAZZ Waiting for Buy signal on JAZZ with https://t.co/DFtBhic4Wk https://t.co/BlVAJc3Th3 November 25th 2021, 11:11pm |
 |
@ChartMill $JAZZ was analyzed by 25 analysts. The buy consensus is at 85%. So analysts seem to be very confident about $JAZZ.… https://t.co/MjjPuoTLJQ November 25th 2021, 1:11pm |
 |
@greedisgood70 @stock_mj Any $JAZZ longs from the GW merger? Was poking around on that one today. Any thoughts or feelings? November 24th 2021, 8:11pm |
 |
@LeeSinTrade1 $JAZZ Awaiting buy signal. Trading simplified, free trial at https://t.co/z9Zossz5Nf https://t.co/6oJGJt3K4Y November 24th 2021, 12:11pm |
|
@Ba4Saso $JAZZ Waiting for Buy signal on JAZZ with https://t.co/DFtBhic4Wk https://t.co/aOwiJfkyzn November 23rd 2021, 3:11pm |
 |
@SweepCastApp SweepCast alerted: $JAZZ with Unusual Options Activity Alerted on $130 CALL Expiring: 03-18-2022 worth 39K? |? You… https://t.co/SsMIfn8mh3 November 22nd 2021, 7:11pm |
|
@newsfilterio EXCLUSIVE: Cannabis-Based Drug Approved For Cancer Treatment In Peru $JAZZ https://t.co/6pZA5lPxfb November 22nd 2021, 6:11pm |
 |
@QueensCrypto RT @JavierHasse: EXCLUSIVE: Cannabis-Based Drug Approved For Cancer Treatment In Peru | Benzinga $CLVR $JAZZ https://t.co/mRWdRHmZA1 via @b… November 22nd 2021, 4:11pm |
 |
@JavierHasse EXCLUSIVE: Cannabis-Based Drug Approved For Cancer Treatment In Peru | Benzinga $CLVR $JAZZ https://t.co/mRWdRHmZA1 via @benzinga November 22nd 2021, 2:11pm |
|
@MarcJacksonLA $CMPS $JAZZ Better Buy: Compass Pathways vs. Jazz Pharmaceuticals | NASDAQ https://t.co/QBGRL3KhQs November 21st 2021, 3:11pm |
|
@MarcJacksonLA $JAZZ Goldman Sachs Resumes Coverage Of Jazz Pharmaceuticals With A Buy Rating, $198 PT https://t.co/0as1obZXkQ November 19th 2021, 5:11pm |
 |
@mediasentiment $JAZZ new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 248 November 19th 2021, 1:11pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?